DID BRENDA JOETTE O’BRIEN CAUSE YOU INVESTMENT LOSSES?
Brenda O’Brien Of Oppenheimer & Co. Has A Customer Complaint For Alleged Broker Misconduct
Who is Brenda O’Brien of Oppenheimer & Co.?
Brenda O’Brien (CRD #1587005) who is currently registered with Oppenheimer & Co.and located in St. Louis, Missouri is a subject of one of our many securities industry sales practice abuse investigations.
Brenda O’Brien Customer Complaint
Brenda O’Brien has been the subject of at least one customer complaint that we know about, which was filed in the last year to recover investment losses. The allegations made in the FINRA reported customer complaint for investment losses were client’s attorney alleged that no one discussed annuity redemption options with the client, nor did anyone discuss the risks associated with the annuity options or review the suitability standards. Brenda O’Brien’s customer complaint was denied and, to date, the customer has not taken any further action.
Brenda O’Brien Red Flags & Your Rights As An Investor
Of course, Brenda O’Brien did not admit to any of the allegations. But regardless of whether an arbitration award was entered, a settlement occurred, or the customer complaint is still pending, the allegations made by customers are red flags which should put all current and former customers of Brenda O’Brien at Oppenheimer & Co. on alert to review carefully the activity and performance of their accounts and question whether Brenda O’Brien has engaged in any stockbroker misconduct that may have caused them investment losses. The large number of customer complaints at Oppenheimer & Co. also raises questions about the brokerage firm’s supervisory practices. If these red flags raise questions, call us and we will inform you of your rights as an investor.
File A Claim To Recover Your Investment Losses At Oppenheimer & Co. Due To Brenda O’Brien
If you have questions about Oppenheimer & Co. and/or Brenda O’Brien and the management or performance of your accounts, please contact Attorney Pearce for a free initial consultation via email or Toll Free at 1-800-732-2889.